Advertisement · 728 × 90

Posts by Simran Gupta

Post image Post image Post image Post image

🔥 Late Breakers
SNAP platform RCT| Adjunctive Clindamycin in S.aureus bacteraemia
❌ No mortality benefit
90d mortality:16.9% vs 15.2% aOR 1.16 (CrI cross 1)
📊PPSup(~7%)→Futility threshold reached
⚠️ICU subgp:numerically worse with clinda
⚖️CDAD:no # (~2%)😯
#ESCMIDGlobal2026 #idsky

1 day ago 20 9 1 2
Post image

Late-breaking #Lancet SCOUT RCT results at #ESCMIDGlobal2026:

💊 Day 7 clinical resolution
• Nitrofurantoin: 74%
• Pivmecillinam: 70%
• Fosfomycin (2 doses): 67%
• Fosfomycin (single dose): 59%

🔑 single-dose fosfomycin underperforms vs standard short-course regimens

2 days ago 24 9 3 1
Post image Post image Post image Post image

🔥 💥Late-Breakers |COBRA RCT
1-day of antibiotic treatment after adequate endoscopic biliary drainage is non-inferior to 4-7 days in adults with acute cholangitis.
💡 Shorter is better+source control
Practice-changing? #ESCMIDGlobal2026 #idsky

2 days ago 25 8 0 0

Of note this is second condition that in med school I learned needed anaerobic coverage.

Anaerobic coverage not needed in:
1) PNA after aspiration ❌
2) Sinusitis ❌

2 days ago 3 1 0 0
Post image Post image Post image Post image

Highlights from late-breaking @TheLancet at #ESCMIDGlobal2026 📊

🔹 WGS + AI for RR-TB → better outcomes
🔹 UTI → nitrofurantoin best; fosfomycin worst
🔹 H5 immunity → partial cross-protection
🔹 M. pneumoniae CAP → steroids speed recovery

🚀 Precision + smarter antimicrobial use are shaping ID

2 days ago 23 9 4 3

@kottonnelson.bsky.social that’s my mentor!!

5 days ago 1 0 0 0
Preview
One-Month Treatment for Latent Tuberculosis Why aren’t we using it?

One-month treatment for latent tuberculosis.

Why aren't we using it? (Hint: We should.)

voices.nejm.org/doi/full/10....

2 weeks ago 22 13 3 0
Video

ID fellow Alejandro De La Hoz Gomez, MD, of Mass General Brigham shares three things people don’t realize about a career in infectious diseases. #WhyILoveID

1 month ago 9 4 0 1

Say it louder for the people in the back

1 month ago 0 0 0 0
Post image

Very excited for this next (and last) stage of my training! We’re moving to New York!

4 months ago 1 0 0 0
Advertisement
Preview
Antagonistic interaction between posaconazole and olorofim in a murine model of invasive pulmonary aspergillosis AbstractBackground. Olorofim is a new antifungal agent with a novel mechanism of action with in vitro activity against Aspergillus fumigatus and other clin

Antagonistic interaction between posaconazole & olorofim in a murine model of invasive pulmonary aspergillosis

Posaconazole ⬇️ the effect of olorofim in vivo. Combination of olorofim+azole likely efficacious in wt infections, may be suboptimal in azole R infections

academic.oup.com/jac/article/...

6 months ago 45 5 9 2

Ah yes, the famously medium-spectrum doxycycline.

It only covers
Staphylococci
Pneumococci
Beta haemolytic Streptococci
Actinomyces
Mycoplasma
Chlamydophila
Legionella
H.influenzae
Moraxella catarrhalis
ESBL E.coli UTI
Pseudomonas UTI(maybe!)
Burkholderia pseudomallei
Vibrio
H.pylori

1/2

7 months ago 18 4 4 1

TLDR; We propose an optimized ASE 2.0 definition:
- allow POA infection diagnosis codes to anchor infection
- include pts discharged alive on QAD 3
- include hypotension w/out pressors (>/= 2 readings in 6h)
- include NIV or HFNC (>/= 2 days)
- minor changes in Plt, Cr, and Tbili thresholds

8 months ago 1 2 0 0

Good perspective from @simrangmd.bsky.social et al re use of PCT in ICU.

Particularly pertinent that as data and practice keep pointing towards shorter antibiotic course therapy, the window for diagnostic stewardship will narrow, limiting PCT benefit.
#IDSky #ClinMicro #AMR

9 months ago 6 2 0 0

Check out our viewpoint!

9 months ago 0 0 0 0
Post image

This is by far the most common vaccine I strongly recommend in ID adult clinical practice. As ID doctors, we see some truly severe cases of zoster, with post-zoster sequelae that may last months or even rarely be permanent. #IDSky doi.org/10.1093/cid/...

9 months ago 64 16 3 2
Reassessing Procalcitonin-Guided Antibiotic Therapy in Critically Ill Patients with Sepsis: Lessons from the ADAPT-Sepsis Trial AbstractRandomized trials of procalcitonin-guided algorithms to discontinue antibiotics in critically ill patients with sepsis report reduced antibiotic duration and possible mortality benefit. However, open-label trial designs, inconsistent algorithm adherence, and unclear stewardship practices have limited confidence in procalcitonin’s benefit. The ADAPT-Sepsis trial addressed several of these gaps through a concealed intervention, robust stewardship, and head-to-head comparison with CRP. Procalcitonin-guided care reduced antibiotic use without significantly impacting mortality, while CRP-guided care showed no benefit. However, algorithm adherence was suboptimal and the absolute reduction in antibiotic duration with procalcitonin was only one day. As shorter fixed-duration therapy becomes standard, procalcitonin’s utility in the ICU may decline. Embedding procalcitonin and other biomarkers into multifaceted stewardship strategies, and addressing barriers to clinician trust and implementation, is essential. Future research should also evaluate whether biomarker use earlier in the sepsis care pathway, particularly in Emergency Departments, can improve early diagnostic accuracy and enhance patient outcomes.

Procalcitonin-guided care cut antibiotic use by 1 day in sepsis patients but had no mortality impact. CRP showed no benefit. Adherence was low; future focus on early biomarker use is needed. 📉💊

#idsky

10 months ago 2 1 0 0
Herpes Zoster Vaccination and Dementia Occurrence

Herpes Zoster Vaccination and Dementia Occurrence

Herpes zoster vaccination eligibility reduced the probability of new dementia diagnoses, suggesting its potential preventive effect.

https://ja.ma/4lagSB6

10 months ago 20 10 0 1
Advertisement
Post image

🍾Last evening, the MGH & BWH ID faculty celebrated graduates of the MGB ID & MGH Transplant ID Fellowships, along with their families. It was a heartwarming celebration of stories, accolades, laughter, and tears. Special thanks go to our featured speakers Dr. Eric Rubin & Dr. Gabriel Motoa Cardona.🤩

10 months ago 7 2 0 1
Post image

Last few weeks with this BWH crew! @mgb-id-fellows.bsky.social

10 months ago 2 1 0 0
Preview
Social Media Savvy, It's More Than Just the #Hashtags: How the Use of Social Media in Transplant Infectious Diseases Can Impact the Field and Patients

‼️Our new paper on social media in #TxID is officially out in @thetxidjournal.bsky.social

We summarize findings from our #TxIDChat @txidfellows.bsky.social

We discuss recs for trainees, career advancement, & future directions in this changing landscape. Check it out!

dx.doi.org/10.1111/tid....

1 year ago 18 7 1 2
Preview
Trump Pauses Disbursements to Program Supplying H.I.V. Treatment Worldwide Pepfar, which is estimated to have delivered lifesaving treatment as many as 25 million people in 54 countries, faces a funding delay of as long as 180 days.

This will kill so many people living with HIV who depend on PEPFAR programs to stay on their HIV treatment driving further HIV drug resistance.

www.nytimes.com/2025/01/24/u...

1 year ago 866 468 44 129

ICE was in my hospital today…

i am so beyond angry—this is unacceptable

stay away from our patients and let us do our jobs

1 year ago 12313 2617 329 118

CDC's Morbidity and Mortality Weekly Report (MMWR) has provided real-time data and analysis about disease outbreaks and emerging health threats without a break every week since 1960.

Until today.

1 year ago 4935 2286 139 222
Preview
Trump's Gag Order Halts CDC Publication MMWR did not publish as usual at 1 p.m. today

Trump's Gag Order Halts CDC Publication www.medpagetoday.com/infectiousdi... For the first time in its more than 60-year history, the CDC's Morbidity and Mortality Weekly Report (MMWR) did not go out as scheduled.

1 year ago 16 11 1 2

Scientific advancements aside, this is economically irresponsible

Every $1 spent by NIH generates $2.46

For example, in 2023, $47B in NIH spending generated ~$93B

Halting NIH spending will LOSE the US a lot of money (and talent)

1 year ago 1952 950 59 73

For those asking how unusual it is for NIH review panels to be cancelled: I do not recall study sections ever being cancelled during my 30-year career except for during the “sequestration” period around 2012-2013 when there was, I think, a government shutdown.

1 year ago 165 47 4 4
Advertisement

Oh. My.

1 year ago 1 0 0 0
Preview
Outcomes of Coccidioides Seropositive Solid Organ... : Transplantation by enzyme immunoassay (EIA-IgM-only), although this result may be falsely positive. Methods. We conducted a retrospective study at a large-volume transplant center in an endemic coccidioidomycosis ...

Excited to share our research on duration of antifungal ppx for Cocci in SOT!

TLDR; For patients repeatedly pos for EIA-IgM-only w no seroconversion, compatible clinical illness, or rads findings, discontinuing antifungal ppx may be reasonable after 1st posttxp yr

journals.lww.com/transplantjo...

1 year ago 6 2 1 1
Preview
Time to Staphylococcus aureus Blood Culture Positivity as a risk marker of Infective Endocarditis: A Retrospective Cohort Study Short time to blood culture positivity (TTP) was an independent risk factor of infective endocarditis in this large (N=1703) Staphylococcus aureus bacterem

🆕💫Retrospective Cohort Study
Time to Staphylococcus aureus Blood Culture Positivity as a risk marker of IE
Short TTP was associated wit IE
NPV >95% suggests that TTP>13h can be used to risk stratify pts with SAB #idsky #EMIMCC
academic.oup.com/cid/article/...
academic.oup.com/cid/advance-...

1 year ago 21 8 4 3